Molecule Name |
DB11592
|
DrugBank Groups |
Experimental
|
Cluster No |
1277
|
Smiles |
S1(C3(N(C(C(=O)O)=C(C1)C=CC2(=C([N+](=O)[O-])C=C([N+](=O)[O-])C=C2))C(=O)C3NC(=O)CC=4(SC=CC=4)))
|
Download |
mol2, pdbqt
|
TPSA |
350,09
|
Non-H Atoms |
35
|
Non-C/H Atoms |
14
|
Metal-Atoms |
0
|
Electronegative Atoms |
14
|
Stereo Centers |
2
|
Rotatable Bonds |
8
|
Rings Closures |
4
|
Small Rings |
4
|
Aromatic Rings |
2
|
Aromatic Atoms |
11
|
sp3-Atoms |
8
|
Symmetric atoms |
0
|
cLogS |
-4,625
|
MW |
516,51
|
cLogP |
0,9631
|
HBA |
12
|
HBD |
2
|
Ro5 violations |
2
|
Druglikeness |
7,3172
|
DrugScore |
0,572393606885751
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB-
|
Human Intestinal Absorption |
HIA-
|
Caco-2 Permeability |
Caco2-
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-2,8161
|
Caco-2 Permeability 2 |
0,1207
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,2747
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,576
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,3324
|
Carcinogenicity (Three-class) |
Non-required
|